Metal carbonate-based nanomaterials have received significant
attention
in environmental to biomedical applications due to their practical
availability, low cost, safety, biocompatibility, and scalability.
However, so far, metal carbonate nanostructures are only limited to
calcium (Ca), magnesium (Mg), barium (Ba), strontium (Sr), and iron
(Fe) carbonates. Moreover, enzyme mimetic activities of direct metal
carbonate nanoparticles (NPs) are not yet reported. Given the advantages
of metal carbonates, it is highly desired to develop novel metal carbonate
nanostructures to address environmental and biological needs. Thus,
in the present work, we have developed biocompatible cerium oxycarbonate
nanoparticles (Ce2(CO3)2O·H2O NPs) and systematically studied the enzymatic, computed
tomography (CT) contrast and nanocarrier properties. Results reveal
that Ce2(CO3)2O·H2O NPs exhibit enzyme oxidase-like activities by oxidating the colorless
3,3′,5,5′-tetramethylbenzidine (TMB) to produce oxidized
TMB (ox-TMB) in the absence of hydrogen peroxide (H2O2), and it obeys the Michaelis–Menten enzymatic pathway.
In addition, Ce2(CO3)2O·H2O NPs possess good CT contrast properties in a concentration-dependent
manner. Moreover, in vitro cellular uptake imaging studies demonstrated
the excellent nanocarrier properties of Ce2(CO3)2O·H2O NPs. Finally, biocompatible studies
reveal that the present Ce2(CO3)2O·H2O NPs are biocompatible and safer for practical
applications. Overall, we believed that the present multifunctional
properties of Ce2(CO3)2O·H2O NPs could be a potential candidate in future environmental
and biomedical applications.